We are excited to be working with Texas Tech University on the recently funded National Science Foundation grant project entitled, Design of functionally-tested, genomics-informed personalized cancer therapy drug treatment plans. This project is led by Dr. Ranadip Pal at TTU, with Dr. Keller at cc-TDI as co-investigator. The goal? Mathematical approaches to combining personalized, synergistic drugs for relapsed cancer… with patient safety in mind.
cc-TDI is a qualified 501(c)(3) charitable organization registered with the IRS(consult with a CPA regarding specific tax implications)